Dihydroergotamine Mesylate and Morphine Immediate-Release Tablets and Capsules
Determining the interaction of Dihydroergotamine Mesylate and Morphine Immediate-Release Tablets and Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Morphine injection
- Dihydroergotamine Mesylate-Morphine Injection PF
- Dihydroergotamine Mesylate-Morphine Long-Acting Tablets
- Dihydroergotamine Mesylate-Morphine Oral Concentrate (20 mg/mL)
- Dihydroergotamine Mesylate-Morphine Oral Solution
- Dihydroergotamine Mesylate-Morphine Sulfate
- Morphine Immediate-Release Tablets and Capsules-Dihydroergotamine nasal
- Morphine Immediate-Release Tablets and Capsules-Dihydroergotamine Nasal Spray
- Morphine Immediate-Release Tablets and Capsules-Dilacor XR
- Morphine Immediate-Release Tablets and Capsules-Dilantin
- Morphine Immediate-Release Tablets and Capsules-Dilantin Infatabs
- Morphine Immediate-Release Tablets and Capsules-Dilantin injection